TRPIX
Price
$53.46
Change
+$0.45 (+0.85%)
Updated
Jun 2 closing price
Net Assets
33.31B
VIVAX
Price
$83.19
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

TRPIX vs VIVAX

Header iconTRPIX vs VIVAX Comparison
Open Charts TRPIX vs VIVAXBanner chart's image
TRPIX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
TRPIX vs. VIVAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRPIX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 238B vs. TRPIX (33.3B). VIVAX pays higher dividends than TRPIX: VIVAX (1.76) vs TRPIX (0.96). TRPIX was incepted earlier than VIVAX: TRPIX (11 years) vs VIVAX (34 years). TRPIX (0.58) is less costly to investors than VIVAX (0.17). TRPIX is a more actively managed with annual turnover of: 59.50 vs. VIVAX (8.00). VIVAX has a lower initial minimum investment than TRPIX: VIVAX (0) vs TRPIX (500000). VIVAX annual gain was more profitable for investors over the last year : 23.23 vs. TRPIX (15.87). VIVAX return over 5 years is better than : 50.69 vs. TRPIX (14.54).
TRPIXVIVAXTRPIX / VIVAX
Total Expense Ratio0.570.17335%
Annual Report Gross Expense Ratio0.580.17341%
Fund Existence11 years34 years-
Gain YTD11.17910.667105%
Front LoadN/AN/A-
Min. Initial Investment5000000-
Min. Initial Investment IRAN/AN/A-
Net Assets33.3B238B14%
Annual Yield % from dividends0.961.7655%
Returns for 1 year15.8723.2368%
Returns for 3 years41.9853.1679%
Returns for 5 years14.5450.6929%
Returns for 10 years85.80150.4357%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCCAX42.10N/A
N/A
Columbia Contrarian Core A
SPSCX22.32N/A
N/A
Sterling Capital Behav Sm Cp Val Eq Intl
QICRX18.42N/A
N/A
AQR International Multi-Style R6
MIEFX22.26N/A
N/A
Matthews Emerging Markets Equity Ins
BMSSX16.63N/A
N/A
MFS Blended Research Mid Cap Eq R2